The invention relates to a novel compound having an FGFR inhibition activity, and a preparation method and an application thereof. The structure of the compound is represented by formula I, and all groups and substituent groups in the formula I are as defined in the description. The invention also discloses the preparation method of the compound, and a use of the compound in the preparation of drugs for treating and/or preventing tumor correlated diseases and/or FGFR correlated diseases.